$14.6 Billion is the total value of LANSDOWNE PARTNERS (UK) LLP's 154 reported holdings in Q4 2015. The portfolio turnover from Q3 2015 to Q4 2015 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TMUS | T MOBILE US INC | $114,936,000 | -1.7% | 2,938,037 | 0.0% | 0.79% | -20.0% | |
| CYTK | CYTOKINETICS INC | $24,287,000 | +56.4% | 2,321,865 | 0.0% | 0.17% | +27.5% | |
| ISRG | INTUITIVE SURGICAL INCput | $10,923,000 | +18.8% | 20,000 | 0.0% | 0.08% | -2.6% | |
| SMMT | SUMMIT THERAPEUTICS PLCspons ads | $10,695,000 | +10.5% | 930,000 | 0.0% | 0.07% | -11.0% | |
| C | CITIGROUP INC | $10,150,000 | +4.3% | 196,127 | 0.0% | 0.07% | -14.6% | |
| OXFD | OXFORD IMMUNOTEC GLOBAL PLC | $8,307,000 | -14.8% | 722,354 | 0.0% | 0.06% | -30.5% | |
| ETFC | E TRADE FINANCIAL CORP | $7,053,000 | +12.6% | 237,964 | 0.0% | 0.05% | -9.4% | |
| CCL | CARNIVAL CORPpaired ctf | $4,421,000 | +9.6% | 81,153 | 0.0% | 0.03% | -11.8% | |
| SYY | SYSCO CORP | $4,204,000 | +5.2% | 102,545 | 0.0% | 0.03% | -14.7% | |
| BAC | BANK AMER CORP | $3,637,000 | +8.0% | 216,112 | 0.0% | 0.02% | -10.7% | |
| LYV | LIVE NATION ENTERTAINMENT IN | $2,153,000 | +2.2% | 87,615 | 0.0% | 0.02% | -16.7% | |
| RCL | ROYAL CARIBBEAN CRUISES LTD | $1,655,000 | +13.6% | 16,354 | 0.0% | 0.01% | -8.3% | |
| MSGN | MSG NETWORK INCcl a | $1,486,000 | -71.2% | 71,455 | 0.0% | 0.01% | -76.7% | |
| BACWSA | BANK AMER CORP*w exp 01/16/201 | $1,322,000 | +1.6% | 227,136 | 0.0% | 0.01% | -18.2% | |
| AMBC | AMBAC FINL GROUP INC | $1,003,000 | -2.6% | 71,185 | 0.0% | 0.01% | -22.2% | |
| EL | LAUDER ESTEE COS INCcl a | $1,006,000 | +9.1% | 11,423 | 0.0% | 0.01% | -12.5% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- LANSDOWNE DEVELOPED MARKETS STRATEGIC INVESTMENT MASTER FUND LTD #1
- LANSDOWNE GLOBAL FINANCIALS MASTER FUND LTD. #2
- LANSDOWNE DEVELOPED MARKETS MASTER FUND LTD #3
- LANSDOWNE DEVELOPED MARKETS LONG ONLY MASTER FUND LTD #4
- LANSDOWNE DM LONG ONLY CAYMAN MASTER LP #5
- Lansdowne Lothbury Master Fund Ltd #6
- LANSDOWNE DMLO DAVIES STREET LP #7
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-02-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| DELTA AIR LINES INC DEL | 41 | Q2 2024 | 25.1% |
| EATON CORP PLC | 36 | Q2 2024 | 11.6% |
| TAIWAN SEMICONDUCTOR MFG LTD | 28 | Q2 2024 | 30.1% |
| AMAZON COM INC | 24 | Q2 2024 | 13.9% |
| MANCHESTER UTD PLC NEW | 22 | Q3 2019 | 1.0% |
| SUMMIT THERAPEUTICS PLC | 22 | Q2 2020 | 0.6% |
| JPMORGAN CHASE & CO | 20 | Q1 2019 | 19.9% |
| CITIGROUP INC | 20 | Q4 2020 | 12.2% |
| FIRST SOLAR INC | 20 | Q3 2021 | 4.2% |
| UNITED TECHNOLOGIES CORP | 20 | Q1 2020 | 3.7% |
View LANSDOWNE PARTNERS (UK) LLP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Soho House & Co Inc. | February 13, 2024 | 2,619,141 | 4.9% |
| Supernova Partners Acquisition Co II, Ltd. | February 14, 2022 | 2,152,911 | 6.2% |
| Summit Therapeutics plc | June 17, 2020 | 13,664,880 | 4.1% |
| Manchester United plcSold out | February 14, 2020 | 0 | 0.0% |
| CYTOKINETICS INC | January 30, 2018 | 2,647,981 | 4.9% |
| RESPONSE GENETICS INCSold out | February 12, 2016 | 0 | 0.0% |
View LANSDOWNE PARTNERS (UK) LLP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-28 |
| 13F-HR | 2024-08-14 |
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-02-14 |
| SC 13G | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-10 |
| SC 13G | 2023-02-08 |
View LANSDOWNE PARTNERS (UK) LLP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.